• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Globus pallidus focused ultrasound ablation improved motor symptoms in patients with medication refractory Parkinson’s disease

byZain Cheema
May 1, 2023
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

Click here to read this study in NEJM

RELATED REPORTS

Exenatide does not slow Parkinson’s disease progression compared to placebo

The Scan by 2 Minute Medicine®: Florida Trans Youth Care Ban Halted, Tendon Injuries in Basketball, A Blood Test for Parkinson’s Disease, Screen Time and Language Development

Lixisenatide as a treatment for early Parkinson’s disease progression

Tags: dyskinesiaglobus pallidusmotor dysfunctionParkinson’s Diseaseultrasound ablation
Previous Post

Differences in cardiovascular health between sexual minorities and heterosexual adults

Next Post

Higher protein doses do not improve outcomes in mechanically ventilated patients with high nutritional risk

RelatedReports

Levodopa for Parkinson’s disease more effective than newer generation therapies
Chronic Disease

Exenatide does not slow Parkinson’s disease progression compared to placebo

April 25, 2025
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Florida Trans Youth Care Ban Halted, Tendon Injuries in Basketball, A Blood Test for Parkinson’s Disease, Screen Time and Language Development

June 25, 2024
Brain lesions on MRI linked with subsequent increased stroke risk
Chronic Disease

Lixisenatide as a treatment for early Parkinson’s disease progression

May 23, 2024
The LEAP trial: levodopa not associated with a disease-modifying effect in Parkinson’s disease
Chronic Disease

Freezing of gait is associated with sleep disorders in patients with Parkinson’s disease

January 9, 2024
Next Post

Higher protein doses do not improve outcomes in mechanically ventilated patients with high nutritional risk

Adjunctive TMP-SMX (Bactrim) associated with higher clinical cure rates for cutaneous abscesses

Low household income associated with worse outcomes for estrogen receptor-positive breast cancer

ABCD2 Score: Predicting Early Stroke Risk After Transient Ischemic Attack (TIA) [Classics Series]

The NICE-SUGAR trial: Intensive glycemic control harmful in the ICU [Classics Series]

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Pfizer’s Talzenna combo significantly delays prostate cancer progression
  • Bottom-vented bottles may not reduce gastrointestinal discomfort in infants
  • Ketorolac administration after cesarean delivery may reduce postoperative opioid use
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.